Evidence map›Paper›PMID 29399168›Full record

ArticleOncology letters2018

Effect of FOLFOX4 combined with

Zheng Chen, Zhenyu Zhou, Zhigang Hu, Qiaodong Xu, Jie Wang

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. A review ofFrontiers in pharmacology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Zheng ChenDepartment of General Surgery, Guangdong Province Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Research Center for Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Haizhu, Guangzhou 510220, P.R. China.
Zhenyu ZhouDepartment of General Surgery, Guangdong Province Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Research Center for Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Haizhu, Guangzhou 510220, P.R. China.
Zhigang HuDepartment of General Surgery, Guangdong Province Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Research Center for Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Haizhu, Guangzhou 510220, P.R. China.
Qiaodong XuDepartment of General Surgery, Guangdong Province Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Research Center for Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Haizhu, Guangzhou 510220, P.R. China.
Jie WangDepartment of General Surgery, Guangdong Province Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Research Center for Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Haizhu, Guangzhou 510220, P.R. China.
Sun Yat-sen Memorial Hospital · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the study was to investigate the effect of FOLFOX4 regimen combined with

Indexed as

Brucea javanica emulsionchemotherapygastric cancervascular endothelial growth factor

Identifiers

PMID29399168
PMCPMC5772695
OpenAlexW2770721444

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.